Retrospective study of the clinicopathologic factors of recurrent Ameloblastoma of the jaws

Simple item page
dc.contributor.authorJames, O.
dc.contributor.authorAdamson, O.O.
dc.contributor.authorFashina, A.A.
dc.contributor.authorAdeyemi, M.O.
dc.contributor.authorAgbogidi, F.O.
dc.contributor.authorAdekunle, A.A.
dc.contributor.authorAdeyemo, W.L.
dc.contributor.authorLadeinde, A.L.
dc.contributor.authorOgunlewe, M.O.
dc.date.accessioned2021-11-22T10:56:51Z
dc.date.available2021-11-22T10:56:51Z
dc.date.issued2019-10-09
dc.descriptionScholarly articlesen_US
dc.description.abstractBackground: Ameloblastomas are benign, locally aggressive, polymorphic neoplasms of proliferating odontogenic epithelial origin. Clinically, ameloblastoma appears as an aggressive odontogenic tumour, often asymptomatic and slow growing, with no evidence of swelling. Aim: To retrospectively review recurrent ameloblastomas cases during a 10-year period and to determine the recurrence rate of ameloblastoma and clinicopathologic factors involved in recurrence. Methodology: Records of clinicopathologically diagnosed and treated cases of recurrent ameloblastoma for a period of 10 years (2008 –2018) were obtained from the Department of Oral and Maxillofacial surgery, LUTH. Information derived include patients’ demographics, initial diagnosis, previous surgery done, year of recurrence, localisation of tumor and histologic diagnosis of recurrent tumor. Results: During the period of this study (2009-2018), 247 ameloblastoma cases were treated during the of which 32 (12%) were recurrent cases. 19 (59.4%) were females while 13 (40.6%) were males. Male to female ratio is 1:1.5. The ages ranges from 11- 60 with a mean of 37.03±12.57. Recurrence was more observed in the mandible 26 (81.3%) than the maxilla 4 (12.5%) and craniofacial region 2 (6.3%). The number of years for recurrence to occur ranges from 1-30 years with median of 4 years and interquartile range of 7.75. Most recurrence occurs between 3-5 years (40.6%) followed by 1-2 years (25%) of initial surgery. Conclusion: The recurrence rate after conservative treatment was higher than that after radical treatment. The choice of treatment should be adapted to the macroscopic and histological characteristics of each tumour.en_US
dc.identifier.citationJames, O. Adamson, O.O. Fashina, A.A. Adeyemi, M.O. Agbogidi, F.O. Adekunle, A.A. Adeyemo, W.L. Ladeinde, A.L. & Ogunlewe, M.O. (2019). Retrospective study of the clinicopathologic factors of recurrent Ameloblastoma of the jaws.en_US
dc.identifier.urihttps://ir.unilag.edu.ng/handle/123456789/9729
dc.language.isoenen_US
dc.subjectRecurrenten_US
dc.subjectAmeloblastomaen_US
dc.subjectReviewen_US
dc.subjectOdontogenic tumouren_US
dc.subjectResearch Subject Categories::ODONTOLOGYen_US
dc.titleRetrospective study of the clinicopathologic factors of recurrent Ameloblastoma of the jawsen_US
dc.typePresentationen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
abstract on recurrent ameloblastoma.docx
Size:
13.49 KB
Format:
Microsoft Word XML
Description:
Abstract oral presentation
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Oral and Maxillofacial Surgery - Conference Papers